586 related articles for article (PubMed ID: 34238294)
21. Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study.
Lin XL; Li QY; Zhao DH; Liu JH; Fan Q
Front Cardiovasc Med; 2022; 9():943185. PubMed ID: 36237913
[TBL] [Abstract][Full Text] [Related]
22. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
23. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project.
Wang W; Yang J; Wang K; Niu J; Liu Y; Ge H;
Cardiovasc Diabetol; 2024 May; 23(1):170. PubMed ID: 38750553
[TBL] [Abstract][Full Text] [Related]
24. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
Gao S; Ma W; Huang S; Lin X; Yu M
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3184-3192. PubMed ID: 34511291
[TBL] [Abstract][Full Text] [Related]
25. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
27. Systemic immune inflammation index and its implication on in-stent restenosis among patients with acute coronary syndrome.
Ösken A; Polat F; Çakir B; Zengin A; Çalik AN; Ünal Dayi Ş; Çam N
Coron Artery Dis; 2024 May; 35(3):209-214. PubMed ID: 38180335
[TBL] [Abstract][Full Text] [Related]
28. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes.
Yang X; Li K; Wen J; Yang C; Li Y; Xu G; Ma Y
Cardiovasc Diabetol; 2024 Jan; 23(1):24. PubMed ID: 38218893
[TBL] [Abstract][Full Text] [Related]
29. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
31. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
32. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
33. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
34. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
35. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
36. Association between oral infections, triglyceride-glucose index, and in-stent restenosis.
Wu Y; Du L; Fan M; Chen X; Tang Y; Wang Y; Wang K; Wang S; Li G
Oral Dis; 2023 Nov; 29(8):3698-3706. PubMed ID: 36321885
[TBL] [Abstract][Full Text] [Related]
37. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
[TBL] [Abstract][Full Text] [Related]
40. High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
J Atheroscler Thromb; 2022 Feb; 29(2):268-281. PubMed ID: 33536384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
